Bruker Corporation (BRKR)
Summary
BRKR Stock Up Post Q1 Earnings & Revenue Beat, Margins Down
Bruker beats Q1 earnings and revenue estimates as Europe growth and strong BSI bookings offset margin pressure and softer organic sales.
Bruker Corporation $BRKR Shares Purchased by Aquatic Capital Management LLC
Aquatic Capital Management LLC raised its holdings in shares of Bruker Corporation (NASDAQ: BRKR) by 120.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 349,596 shares of the medical research company's stock after buying an additional
Artisan Small Cap Fund Q4 2025 Portfolio Activity
During the quarter, we initiated new positions in nLIGHT, Guardant Health and Cellebrite. We also added to Bruker, Hexcel and Penumbra during the quarter. Along with Insmed, we also ended our investment campaigns in Integer Holdings and SharkNinja during the quarter.
Bruker Corporation Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 36 | $1,566.95 | $2,135.26 | $568.31 | 36.27% |
| ABB Alexander Bjornager Bonde Danske Bank A/S | 100 | $4,711 | $5,931.29 | $1,220.29 | 25.9% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 7 | $263.83 | $410.97 | $147.14 | 55.77% |
 Point72 Asset Management LP Point72 Asset Management LP | 952,873 | $38.14M | $55.34M | $17.19M | 45.08% |
 Jeff Ameen Spire Wealth Management | 210 | $7,144.54 | $12,564.3 | $5,419.76 | 75.86% |
Bruker Corporation (BRKR) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Bruker Corporation ever had a stock split?
Bruker Corporation Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Frank H. Laukien CEO | NASDAQ (NGS) Exchange | 116794108 CUSIP |
| US Country | 11,085 Employees | 22 Jun 2026 Last Dividend | - Last Split | 4 Aug 2000 IPO Date |
Overview
Bruker Corporation, alongside its subsidiaries, stands as a pioneer in the development, manufacture, and distribution of advanced scientific instruments, alongside analytical and diagnostic solutions, catering to a global clientele. Headquartered in Billerica, Massachusetts since its inception in 1991, the company's operations span across critical markets including the United States, Europe, and the Asia Pacific. Bruker operates through distinct segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies, each dedicated to pushing the boundaries of research, analysis, and technology in their respective fields.
Products and Services
- Life Science Tools and Systems:
Offering a broad spectrum of life science tools, including single and multiple modality systems tailored for an array of research and diagnostic applications.
- Mass Spectrometry:
Providing advanced life science mass spectrometry solutions that facilitate complex analytical tasks.
- MALDI Biotyper Platform:
A rapid pathogen identification platform complemented by test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology, revolutionizing microbiological analysis.
- Molecular Diagnostics:
Genotype and fluorotype molecular diagnostics kits, enhancing precision in the detection of genetic diseases and conditions.
- Research and Analytical Instruments:
Cutting-edge instruments and solutions for research, analytical, and process analysis, aiding scientific exploration and quality assurance processes.
- COVID-19 Testing Solutions:
Innovative SARS-CoV-2 testing solutions, including the diagnosis of COVID-19 infection and Fluorotyper-SARS-CoV-2 plus kits, supporting global health emergencies.
- Portable Detection Systems:
A range of portable analytical and bioanalytical detection systems for versatile field applications, enhancing mobility in scientific inquiry.
- X-ray Instruments:
Comprehensive X-ray instruments for detailed material characterization and analysis.
- Electron Microscopy Tools:
Advanced analytical tools designed for electron microscopes, offering enhanced imaging and analysis capabilities.
- Atomic Force Microscopy:
Precision instrumentation for atomic force microscopy, enabling non-contact nanometer resolution solution topography.
- Optical Fluorescence Microscopy:
Advanced optical fluorescence microscopy instruments, facilitating cutting-edge biological research and diagnostics.
- Multi-omics Research Support:
Offering products and services to meet the comprehensive needs of researchers in translational research, drug, and biomarker discovery through multi-omics approaches.
- Superconducting Materials:
Production of superconducting materials, including metallic low temperature superconductors, for diverse applications in science and industry.
- Synchrotron and Beamline Instrumentation:
Non-superconducting high technology tools catered to enhance synchrotron and beamline operations, pushing the frontiers of material science.
